Our studies, amongst others, have presented robust evidence that breast cancer with microcalcifications is associated with poor clinical outcome [5, 21–28] and BMP-2 is upregulated in tissues with microcalcifications [3–5]. The gene discussed is BMP2; the disease is breast carcinoma.